Kay AB The early history of the eosinophil Clin Exp Allergy 2015 45 3 575 582 1:STN:280:DC%2BC2MvitFGluw%3D%3D 25544991
Lee JJ Jacobsen EA Ochkur SI McGarry MP Condjella RM Doyle AD et al. Human versus mouse eosinophils: “That which we call an eosinophil, by any other name would stain as red” J Allergy Clin Immunol 2012 130 3 572 584 1:CAS:528:DC%2BC38XhtlSgtL%2FF 22935586 3496419
Jorssen J Van Hulst G Mollers K Pujol J Petrellis G Baptista AP et al. Single-cell proteomics and transcriptomics capture eosinophil development and identify the role of IL-5 in their lineage transit amplification Immunity 2024 57 7 1549 1566.e8 1:CAS:528:DC%2BB2cXhtFWqtrfO 38776917
Park YM Bochner BS Eosinophil survival and apoptosis in health and disease Allergy Asthma Immunol Res 2010 2 2 87 1:CAS:528:DC%2BC3cXlsFSmsbY%3D 20358022 2846745
Jackson DJ Akuthota P Roufosse F Eosinophils and eosinophilic immune dysfunction in health and disease Eur Respir Rev 2022 31 163 210150 35082127 9489126
Syeda MZ Hong T Zhang C Ying S Shen H Eosinophils: a friend or foe in human health and diseases Kidney Dis 2023 9 1 26 38
Diny NL Rose NR Čiháková D Eosinophils in autoimmune diseases Front Immunol 2017 27 8 484
Rothenberg ME Hogan SP The eosinophil Annu Rev Immunol 2006 24 1 147 174 1:CAS:528:DC%2BD28XkvFSqt70%3D 16551246
Gigon L Fettrelet T Yousefi S Simon D Simon H Eosinophils from A to Z Allergy 2023 78 7 1810 1846 1:CAS:528:DC%2BB3sXps1Kgtro%3D 37102676
Hogan SP Rosenberg HF Moqbel R Phipps S Foster PS Lacy P et al. Eosinophils: biological properties and role in health and disease Clin Exp Allergy 2008 38 5 709 750 1:CAS:528:DC%2BD1cXmtlShs7g%3D 18384431
Acharya KR Ackerman SJ Eosinophil granule proteins: form and function J Biol Chem 2014 289 25 17406 17415 1:CAS:528:DC%2BC2cXhtVaisr7F 24802755 4067173
Spencer LA Szela CT Perez SAC Kirchhoffer CL Neves JS Radke AL et al. Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially J Leukoc Biol 2009 85 1 117 123 1:CAS:528:DC%2BD1MXjt12jug%3D%3D 18840671
Fillon S, Ackerman SJ, Furuta GT. Eosinophils. In: Serhan CN, Ward PA, Gilroy DW, editors. Fundamentals of Inflammation. 1st ed. Cambridge University Press; 2010. pp. 86–95. Available from: https://www.cambridge.org/core/product/identifier/CBO9781139195737A019/type/book_part. Cited 11 Aug 2025.
Davoine F, Lacy P. Eosinophil cytokines, chemokines, and growth factors: emerging roles in immunity. Front Immunol. 2014;5. Available from: http://journal.frontiersin.org/article/10.3389/fimmu.2014.00570/abstract. Cited 11 Nov 2024.
Costain DJ Guha AK Liwski RS Lee TDG Murine hypodense eosinophils induce tumour cell apoptosis by a granzyme B-dependent mechanism Cancer Immunol Immunother 2001 50 6 293 299 1:CAS:528:DC%2BD3MXnslWhs7Y%3D 11570582 11036835
Legrand F Driss V Delbeke M Loiseau S Hermann E Dombrowicz D et al. Human Eosinophils Exert TNF-α and Granzyme A-Mediated Tumoricidal Activity toward Colon Carcinoma Cells J Immunol 2010 185 12 7443 7451 1:CAS:528:DC%2BC3cXhsFSltLbE 21068403
Mesnil C Raulier S Paulissen G Xiao X Birrell MA Pirottin D et al. Lung-resident eosinophils represent a distinct regulatory eosinophil subset J Clin Investig 2016 126 9 3279 3295 27548519 5004964
Gurtner A Borrelli C Gonzalez-Perez I Bach K Acar IE Núñez NG et al. Active eosinophils regulate host defence and immune responses in colitis Nature 2023 615 7950 151 157 1:CAS:528:DC%2BB3sXisVKht74%3D 36509106
Li Y Liu S Zhou K Wang Y Chen Y Hu W et al. Neuromedin U programs eosinophils to promote mucosal immunity of the small intestine Science 2023 381 6663 1189 1196 1:CAS:528:DC%2BB3sXhvFWrtr3F 37708282
Dolitzky A Shapira G Grisaru-Tal S Hazut I Avlas S Gordon Y et al. Transcriptional profiling of mouse eosinophils identifies distinct gene signatures following cellular activation Front Immunol 2021 14 12 802839
Ramirez GA Yacoub MR Ripa M Mannina D Cariddi A Saporiti N et al. Eosinophils from physiology to disease: a comprehensive review Biomed Res Int 2018 2018 1 28
Gaur P Zaffran I George T Rahimli Alekberli F Ben-Zimra M Levi-Schaffer F The regulatory role of eosinophils in viral, bacterial, and fungal infections Clin Exp Immunol 2022 209 1 72 82 35467728 9307229
Berek C Eosinophils: important players in humoral immunity Clin Exp Immunol 2015 183 1 57 64 26291602 4687508
Throsby M Herbelin A Pléau JM Dardenne M CD11c+ Eosinophils in the Murine Thymus: Developmental Regulation and Recruitment upon MHC Class I-Restricted Thymocyte Deletion J Immunol 2000 165 4 1965 1975 1:CAS:528:DC%2BD3cXls1KmsL4%3D 10925279
Weller PF Spencer LA Functions of tissue-resident eosinophils Nat Rev Immunol 2017 17 12 746 760 1:CAS:528:DC%2BC2sXhsVKntr3M 28891557 5783317
Agache I Beltran J Akdis C Akdis M Canelo‐Aybar C Canonica GW et al. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI guidelines ‐ recommendations on the use of biologicals in severe asthma Allergy 2020 75 5 1023 1042 1:CAS:528:DC%2BB3cXpsVCqsLY%3D 32034960
Bafadhel M, McKenna S, Terry S, Mistry V, Reid C, Haldar P, McCormick M, et al. Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med. 2011;184(6):662–71.
Saitoh T Kusunoki T Yao T Kawano K Kojima Y Miyahara K et al. Relationship between epithelial damage or basement membrane thickness and eosinophilic infiltration in nasal polyps with chronic rhinosinusitis Rhinology 2009 47 275 279 1:STN:280:DC%2BD1MjgtFKntQ%3D%3D 19839250
Limberg MM Weihrauch T Gray N Ernst N Hartmann K Raap U Eosinophils, Basophils, and Neutrophils in Bullous Pemphigoid Biomolecules 2023 13 7 1019 1:CAS:528:DC%2BB3sXhs1SrsLnO 37509055 10377006
Kiehl P Falkenberg K Vogelbruch M Kapp A Tissue eosinophilia in acute and chronic atopic dermatitis: a morphometric approach using quantitative image analysis of immunostaining Br J Dermatol 2001 145 5 720 729 1:STN:280:DC%2BD3MnovFyrsA%3D%3D 11736895
Filippone RT Sahakian L Apostolopoulos V Nurgali K Eosinophils in inflammatory bowel disease Inflamm Bowel Dis 2019 25 7 1140 1151 30856253
Egan M Furuta GT Eosinophilic gastrointestinal diseases beyond eosinophilic esophagitis Ann Allergy Asthma Immunol 2018 121 2 162 167 29940308
Watanabe H Recent advances in drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms J Immunol Res 2018 2018 1 10
Valent P Klion AD Roufosse F Simon D Metzgeroth G Leiferman KM et al. Proposed refined diagnostic criteria and classification of eosinophil disorders and related syndromes Allergy 2023 78 1 47 59 1:CAS:528:DC%2BB38XislegtrbP 36207764
Morales-Camacho RM Caballero-Velázquez T Borrero JJ Bernal R Prats-Martín C Hematological neoplasms with eosinophilia Cancers 2024 16 2 337 1:CAS:528:DC%2BB2cXjt1Snsr4%3D 38254826 10814743
Von Wasielewski R Seth S Franklin J Fischer R Hübner K Hansmann ML et al. Tissue eosinophilia correlates strongly with poor prognosis in nodular sclerosing Hodgkin’s disease, allowing for known prognostic factors Blood 2000 95 4 1207 1213
Enblad G Sundstrom C Glimelius B Infiltration of eosinophils in Hodgkin’s disease involved lymph nodes predicts prognosis Hematol Oncol 1993 11 4 187 193 1:STN:280:DyaK2c7ptlWnsw%3D%3D 8144133
Utsunomiya A Ishida T Inagaki A Ishii T Yano H Komatsu H et al. Clinical significance of a blood eosinophilia in adult T-cell leukemia/lymphoma: a blood eosinophilia is a significant unfavorable prognostic factor Leuk Res 2007 31 7 915 920 1:CAS:528:DC%2BD2sXmtlamsL8%3D 17123603
Cook L Rowan A Bangham C Adult T-cell leukemia/lymphoma—pathobiology and implications for modern clinical management Ann Lymphoma 2021 5 29 29
Chen X Yue X Jiang H Yang Q Huang J Pan W et al. Prognostic value of peripheral eosinophil counts in patients with newly diagnosed multiple myeloma Cancer Biol Med 2025 6 1 7 1:CAS:528:DC%2BB28XitFagsrg%3D
Karim AF, Westenberg LEH, Eurelings LEM, Otten R, Gerth van Wijk R. The association between allergic diseases and cancer: a systematic review of the literature. Neth J Med. 2019;77(2):42–66.
Prizment AE Anderson KE Visvanathan K Folsom AR Inverse association of eosinophil count with colorectal cancer incidence: atherosclerosis risk in communities study Cancer Epidemiol Biomark Prev 2011 20 9 1861 1864 1:CAS:528:DC%2BC3MXhtFaiu7rL
Zhan Z Huang Z Xie Z Zhou H Luo Y Chen P et al. Role of eosinophil counts in mediating the association between asthma and colon cancer Clin Translational All 2024 14 12 e70012 1:CAS:528:DC%2BB2cXislyksb3L
Constantinescu A Bull CJ Jones N Mitchell R Burrows K Dimou N et al. Circulating white blood cell traits and colorectal cancer risk: a Mendelian randomisation study Intl J Cancer 2024 154 1 94 103 1:CAS:528:DC%2BB3sXhslShurfM
Zhu JH Xu BJ Pang XY Lian J Gu K Ji SJ et al. Genetic evidence for a causal relationship between innate leukocytes and the risk of digestive system cancers in East Asians and Europeans World J Oncol 2024 15 3 482 491 1:CAS:528:DC%2BB2cXit12qu7bO 38751703 11092417
Wang YY Jia ZH Wang QJ Zhu ZT Eosinophils and drugs for eosinophilia are associated with the risk of colorectal cancer: a Mendelian randomization study Aging 2024 16 16 12050 12062 1:CAS:528:DC%2BB2cXitFensL3F 39181688 11386931
Liang J Zhou X Lin Y Yin H Liu Y Xie Z et al. Prospective study on the association between 36 human blood cell traits and pan-cancer outcomes: a mendelian randomization analysis BMC Cancer 2024 24 1 1442 1:CAS:528:DC%2BB2cXis1SjtLnN 39578790 11583664
Wang JH, Rabkin CS, Engels EA, Song M. Associations between eosinophils and cancer risk in the UK Biobank. Int J Cancer. 2024;155(3):486–92.
Pardo-Cea MA Farré X Esteve A Palade J Espín R Mateo F et al. Biological basis of extensive pleiotropy between blood traits and cancer risk Genome Med 2024 16 1 21 1:CAS:528:DC%2BB2cXjtVWntL0%3D 38308367 10837955
Andersen CL Siersma VD Hasselbalch HC Lindegaard H Vestergaard H Felding P et al. Eosinophilia in routine blood samples as a biomarker for solid tumor development – A study based on The Copenhagen Primary Care Differential Count (CopDiff) Database Acta Oncol 2014 53 9 1245 1250 24913152
Rui-chang Z Hui-zi P Lin Z The causal relationships of granulocytes and melanoma skin cancer: a univariable and multivariable Mendelian randomization study Skin Res Technol 2024 30 8 e70007 39149884 11327865
Liu D Xia J He R Zhu R The causal relationship between eosinophil counts and hepatocellular carcinoma in East Asians: evidence from a Mendelian randomization study Discov Onc 2025 16 1 295 1:CAS:528:DC%2BB2MXmtVKhu78%3D
Wang Z Chen B Fu Y Ou C Rong Q Kong X et al. Eosinophilia and lung cancer: analysis from real-world data and Mendelian randomization study Front Med 2022 9 9 830754
Long K Zhu Z Zheng X Xu G Chen C Ke X White blood cell traits and lung cancer risk: a two-sample mendelian randomization analysis Sci Rep 2025 15 1 4227 1:CAS:528:DC%2BB2MXjt1Cns7w%3D 39905222 11794654
Ren X Zhang L Wang K Li F Causal association of peripheral immune cell counts with risk of prostate cancer: insights from bidirectional Mendelian randomization Front Oncol 2024 29 14 1374927
Sharma G Jain SK Sinha VD Peripheral Inflammatory Blood Markers in Diagnosis of Glioma and IDH Status JNRP 2021 10 12 88 94
Huang Z Wu L Hou Z Zhang P Li G Xie J Eosinophils and other peripheral blood biomarkers in glioma grading: a preliminary study BMC Neurol 2019 19 1 313 1:CAS:528:DC%2BC1MXitlajtb7M 31805879 6894118
Zhang X Li C Xiao L Gao C Zhao W Yang M et al. Predicting individual prognosis and grade of patients with glioma based on preoperative eosinophil and neutrophil-to-lymphocyte ratio CMAR 2020 12 5793 5802 1:CAS:528:DC%2BB3cXisFyjtb%2FI
Madhugiri VS Venkatesan S Dutt A Moiyadi AV Shetty P Gupta T et al. An analysis of eosinophil- and basophil-based indices in patients with glioblastoma and their correlation with survival World Neurosurg 2023 170 e292 300 36368458
Zheng L Yu M Zhang S Prognostic value of pretreatment circulating basophils in patients with glioblastoma Neurosurg Rev 2021 44 6 3471 3478 33765226
Zhong QY Fan EX Feng GY Chen QY Gou XX Yue GJ et al. A gene expression-based study on immune cell subtypes and glioma prognosis BMC Cancer 2019 19 1 1116 1:CAS:528:DC%2BC1MXitlWkt7jE 31729963 6858694
Wei Y, Zhang X, Wang G, Zhou Y, Luo M, Wang S, et al. The impacts of pretreatment circulating eosinophils and basophils on prognosis of stage Ⅰ–Ⅲ colorectal cancer. Asia-Pac J Clncl Oncology. 2018;14(5). Available from: https://onlinelibrary.wiley.com/doi/10.1111/ajco.12871. Cited 23 Jun 2025.
Gao L Yuan C Fu J Tian T Huang H Zhang L et al. Prognostic scoring system based on eosinophil- and basophil-related markers for predicting the prognosis of patients with stage II and stage III colorectal cancer: a retrospective cohort study Front Oncol 2023 14 13 1182944
Alsalman A Al-Mterin MA Abu-Dayeh A Alloush F Murshed K Elkord E Associations of complete blood count parameters with disease-free survival in right- and left-sided colorectal cancer patients JPM 2022 12 5 816 35629238 9146340
Marinkovic M Stojanovic-Rundic S Stanojevic A Ostojic M Gavrilovic D Jankovic R et al. Exploring novel genetic and hematological predictors of response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer Front Genet 2023 31 14 1245594
Prizment AE Vierkant RA Smyrk TC Tillmans LS Lee JJ Sriramarao P et al. Tumor eosinophil infiltration and improved survival of colorectal cancer patients: Iowa Women’s Health Study Mod Pathol 2016 29 5 516 527 1:CAS:528:DC%2BC28XjslCrsLo%3D 26916075 4848192
Fernández-Aceñero MJ Galindo-Gallego M Sanz J Aljama A Prognostic influence of tumor-associated eosinophilic infiltrate in colorectal carcinoma Cancer 2000 88 7 1544 1548 10738211
Nielsen HJ Hansen U Christensen IJ Reimert CM Brnner N Moesgaard F Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue J Pathol 1999 189 4 487 495 1:STN:280:DC%2BD3c%2Fps12gsw%3D%3D 10629548
Harbaum L Pollheimer MJ Kornprat P Lindtner RA Bokemeyer C Langner C Peritumoral eosinophils predict recurrence in colorectal cancer Mod Pathol 2015 28 3 403 413 1:CAS:528:DC%2BC2MXjsFWksrY%3D 25216222
Nagtegaal ID, Marijnen CA, Kranenbarg EK, Mulder-Stapel A, Hermans J, Van De Velde CJ, et al. Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect - a histopathological and immunohistochemical study. BMC Cancer. 2001;1(1). Available from: https://bmccancer.biomedcentral.com/articles/10.1186/1471-2407-1-7. Cited 8 Jul 2025.
Klintrup K Mäkinen JM Kauppila S Väre PO Melkko J Tuominen H et al. Inflammation and prognosis in colorectal cancer Eur J Cancer 2005 41 17 2645 2654 16239109
Ramadan S Saka B Yarikkaya E Bilici A Oncel M The potential prognostic role of peritumoral eosinophils within whole tumor-associated inflammatory cells and stromal histological characteristics in colorectal cancer PJP 2020 71 3 207 220
Baumann E Lechner S Krebs P Kirsch R Berger MD Lugli A et al. Deep learning-based quantification of eosinophils and lymphocytes shows complementary prognostic effects in colorectal cancer patients NPJ Precis Onc. 2025 9 1 175 1:CAS:528:DC%2BB2MXhsVeksb7P
Väyrynen JP Lau MC Haruki K Väyrynen SA Dias Costa A Borowsky J et al. Prognostic significance of immune cell populations identified by machine learning in colorectal cancer using routine hematoxylin and eosin-stained sections Clin Cancer Res 2020 26 16 4326 4338 32439699 7442724
Cho H Lim SJ Won KY Bae GE Kim GY Min JW et al. Eosinophils in colorectal neoplasms associated with expression of CCL11 and CCL24 J Pathol Transl Med 2016 50 1 45 51 26657310
Li N Gao L Ge Y Zhao L Bai C Wang Y Prognostic and predictive significance of circulating biomarkers in patients with advanced upper gastrointestinal cancer undergoing systemic chemotherapy Front Oncol 2023 6 13 1195848
Yang X Wang L Du H Lin B Yi J Wen X et al. Prognostic impact of eosinophils in peripheral blood and tumor site in patients with esophageal squamous cell carcinoma treated with concurrent chemoradiotherapy Medicine 2021 100 3 e24328 1:CAS:528:DC%2BB3MXhvF2qsrzN 33546064 7837956
Zhang Y Ren H Wang L Ning Z Zhuang Y Gan J et al. Clinical impact of tumor-infiltrating inflammatory cells in primary small cell esophageal carcinoma IJMS 2014 15 6 9718 9734 1:CAS:528:DC%2BC2MXjtFymtbc%3D 24886814 4100116
Ishibashi S, Ohashi Y, Suzuki T, Miyazaki S, Moriya T, Satomi S, Sasano H. Tumor-associated tissue eosinophilia in human esophageal squamous cell carcinoma. Anticancer Res. 2006;26(2B):1419–24.
Jacobse J Aziz Z Sun L Chaparro J Pilat JM Kwag A et al. Eosinophils exert antitumorigenic effects in the development of esophageal squamous cell carcinoma Cell Mol Gastroenterol Hepatol 2023 16 6 961 983 1:CAS:528:DC%2BB3sXit1emt73L 37574015 10630122
Abu-Shawer O Abu-Shawer M Haimour A Alhouri A Alkhatib AA Abki M et al. Hematologic markers of distant metastases in gastric cancer J Gastrointest Oncol 2019 10 3 529 536 31183204 6534726
Iwasaki K Torisu M Fujimura T Malignant tumor and eosinophils: I. Prognostic significance in gastric cancer Cancer 1986 58 6 1321 1327 1:STN:280:DyaL283pvVSrtg%3D%3D 3742457
Cuschieri A Talbot IC Weeden S Influence of pathological tumour variables on long-term survival in resectable gastric cancer Br J Cancer 2002 86 5 674 679 1:STN:280:DC%2BD387jvVygsw%3D%3D 11875724 2375301
Ciesielski W Kupryś-Lipińska I Kumor-Kisielewska A Grząsiak O Borodacz J Niedźwiecki S et al. Peripheral eosinophil count may be the prognostic factor for overall survival in patients with pancreatic ductal adenocarcinoma undergoing surgical treatment Biomedicines 2024 12 11 2596 39595162 11591827
Ohkuma R Kubota Y Horiike A Ishiguro T Hirasawa Y Ariizumi H et al. The Prognostic Impact of Eosinophils and the Eosinophil-to-Lymphocyte Ratio on Survival Outcomes in Stage II Resectable Pancreatic Cancer Pancreas 2021 50 2 167 175 1:CAS:528:DC%2BB3MXhslCgtbnF 33565793
Holub K Conill C Unveiling the mechanisms of immune evasion in pancreatic cancer: may it be a systemic inflammation responsible for dismal survival? Clin Transl Oncol 2020 22 1 81 90 1:STN:280:DC%2BB3M%2FntlGisA%3D%3D 31004253
Shinke G, Yamada D, Eguchi H, Iwagami Y, Akita H, Asaoka T, et al. The postoperative peak number of leukocytes after hepatectomy is a significant prognostic factor for cholangiocarcinoma. Mol Clin Onc. 2019. Available from: http://www.spandidos-publications.com/10.3892/mco.2019.1827. Cited 12 Jun 2025.
Liu D Wu J Wang H Dong H Chen L Jia N The enhanced role of eosinophils in radiomics-based diagnosis of microvascular invasion and its association with the immune microenvironment in hepatocellular carcinoma J Hepatocell Carcinoma 2024 Volume 11 1789 1800 11439350
Steel JL Kim KH Dew MA Unruh ML Antoni MH Olek MC et al. Cancer-related symptom clusters, eosinophils, and survival in hepatobiliary cancer: an exploratory study J Pain Symptom Manage 2010 39 5 859 871 20471546 3127169
Shao G Ma Y Qu C Gao R Zhu C Qu L et al. Machine learning model based on the neutrophil-to-eosinophil ratio predicts the recurrence of hepatocellular carcinoma after surgery J Hepatocell Carcinoma 2024 Volume 11 679 691
Wang Q Zhang Z Zhou H Qin Y He J Li L et al. Eosinophil-associated genes are potential biomarkers for hepatocellular carcinoma prognosis J Cancer 2024 15 17 5605 5621 1:CAS:528:DC%2BB2cXitl2mu7zJ 39308686 11414626
Kaur N Zaheer S Sangwan S Ranga S To evaluate eosinophilia (tissue eosinophilia, blood eosinophilia and tissue eosinophilia/blood eosinophilia ratio) in increasing grades/ severity of oral neoplastic lesions J Cancer Res Ther 2023 19 Suppl 1 S206 S211 1:CAS:528:DC%2BB3sXpvFeqt74%3D 37147998
Li D Yang LN Lin JY Wu YZ Tang Z Tu HL et al. Eosinophil dynamics during chemo-radiotherapy correlate to clinical outcome in stage Ⅱ-Ⅳa nasopharyngeal carcinoma patients: results from a large cohort study Radiother Oncol 2023 188 109900 1:CAS:528:DC%2BB3sXhvFWms73I 37660752
Ye M Huang A Yuan B Tan G Ai J Liu H Neutrophil-to-lymphocyte ratio and monocyte-to-eosinophil ratio as prognostic indicators for advanced nasopharyngeal carcinoma Eur Arch Otorhinolaryngol 2024 281 4 1971 1989 38315178
Gopinathan P Bankur R Rodrigues C Anjaly D Bankur P Quantitative analysis of tumor-associated tissue eosinophilia in different histological grades of oral squamous cell carcinoma Indian J Dent Res 2016 27 5 463 27966500
Jain M Kasetty S Sudheendra US Tijare M Khan S Desai A Assessment of tissue eosinophilia as a prognosticator in oral epithelial dysplasia and oral squamous cell carcinoma—an image analysis study Pathol Res Int 2014 19 2014 1 6
Jain S, Phulari RG, Rathore R, Shah AK, Sancheti S. Quantitative assessment of tumor-associated tissue eosinophilia and mast cells in tumor proper and lymph nodes of oral squamous cell carcinoma. J Oral Maxillofac Pathol. 2018;22(1):145. Erratum in: J Oral Maxillofac Pathol. 201822(2):288. Corrected and republished in: J Oral Maxillofac Pathol. 2018;22(1):227–33. https://doi.org/10.4103/jomfp.JOMFP_24_17.
Siddiqui S Jaiswal R Hashmi G Quantitative analysis of tumor-associated tissue eosinophils and tumor-associated blood eosinophils in oral squamous cell carcinoma J Oral Maxillofac Pathol 2020 24 1 131 32508461 7269303
De Paz D Chang K Kao H Lao WW Huang Y Chang Y et al. Clinical implications of tumor-associated tissue eosinophilia in tongue squamous cell carcinoma Laryngoscope 2019 129 5 1123 1129 30098046
Lee TL Chen TH Kuo YJ Lan HY Yang MH Chu PY Tumor-associated tissue eosinophilia promotes angiogenesis and metastasis in head and neck squamous cell carcinoma Neoplasia 2023 35 100855 1:CAS:528:DC%2BB38XivFOgu7jJ 36410227
Oliveira DT Tjioe KC Assao A Sita Faustino SE Lopes Carvalho A Landman G et al. Tissue eosinophilia and its association with tumoral invasion of oral cancer Int J Surg Pathol 2009 17 3 244 249
Peurala E Tuominen M Löyttyniemi E Syrjänen S Rautava J Eosinophilia is a favorable prognostic marker for oral cavity and lip squamous cell carcinoma APMIS 2018 126 3 201 207 1:CAS:528:DC%2BC1cXjs1Wiu7o%3D 29484748
Dorta RG Landman G Kowalski LP Lauris JRP Latorre MRDO Oliveira DT Tumour‐associated tissue eosinophilia as a prognostic factor in oral squamous cell carcinomas Histopathology 2002 41 2 152 157 1:STN:280:DC%2BD38zpvVemug%3D%3D 12147093
Thompson AC Bradley PJ Griffin NR Tumor-associated tissue eosinophilia and long-term prognosis for carcinoma of the larynx Am J Surg 1994 168 5 469 471 1:STN:280:DyaK2M%2FmvVKiuw%3D%3D 7977976
Fujii M Yamashita T Ishiguro R Tashiro M Kameyama K Significance of epidermal growth factor receptor and tumor associated tissue eosinophilia in the prognosis of patients with nasopharyngeal carcinoma Auris Nasus Larynx 2002 29 2 175 181 11893453
Sassier AM Mcclatchey KD Wolf GT Fisher SG Eosinophilic infiltration in advanced laryngeal squamous cell carcinoma Laryngoscope 1995 105 4 413 416
Ercan Çb Çakir B Baçak T Özdemir T Sayin Á Turgut S Prognostic significance of stromal eosinophilic infiltration in cancer of the larynx Otolaryngol Head Neck Surg 2005 132 6 869 873 15944557
Leighton SEJ Teo JGC Leung SF Cheung AYK Lee JCK Van Hasselt CA Prevalence and prognostic significance of tumor-associated tissue eosinophilia in nasopharyngeal carcinoma Cancer 1996 77 3 436 440 1:STN:280:DyaK283ivF2qtQ%3D%3D 8630949
Wang NH Zhang X Sui JD Wang Y Wu YZ Lei QQ et al. Radiation-induced eosinophil increase ratio predicts patient outcomes in non-small celllung cancer Front Oncol 2022 7 12 999555
Alashkar Alhamwe B Yuskaeva K Wulf F Trinkmann F Kriegsmann M Thomas M et al. Peripheral inflammation featuring eosinophilia or neutrophilia is associated with the survival and infiltration of eosinophils within the tumor among various histological subgroups of patients with NSCLC IJMS 2024 25 17 9552 1:CAS:528:DC%2BB2cXit1Wgt73F 39273499 11395097
Sun H Sui B Li Y Yan J Cao M Zhang L et al. Analysis of the significance of immune cell infiltration and prognosis of non-small-cell lung cancer by bioinformatics J Healthcare Eng 2021 2021 1 8 Abdulhay E, editor
Ye L Wang H Li H Liu H Lv T Song Y et al. Eosinophil peroxidase over-expression predicts the clinical outcome of patients with primary lung adenocarcinoma J Cancer 2019 10 4 1032 1038 1:CAS:528:DC%2BC1MXitlCrtrfM 30854109 6400814
Takeuchi E Okano Y Machida H Atagi K Kondou Y Kadota N et al. Eosinophilic pleural effusion due to lung cancer has a better prognosis than non-eosinophilic malignant pleural effusion Cancer Immunol Immunother 2022 71 2 365 372 1:CAS:528:DC%2BB3MXhvFygu7bM 34170380
Willems M Scherpereel A Wasielewski E Raskin J Brossel H Fontaine A et al. Excess of blood eosinophils prior to therapy correlates with worse prognosis in mesothelioma Front Immunol 2023 21 14 1148798
Gunduz S Mutlu H Uysal M Coskun HS Bozcuk H Prognostic value of hematologic parameters in patients with metastatic renal cell carcinoma using tyrosine kinase inhibitors Asian Pac J Cancer Prev 2014 15 8 3801 3804 24870797
Wang HK Wan FN Gu WJ Zhu Y Dai B Shi GH et al. Eosinophil percentage elevation as a prognostic factor for overall survival in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor Oncotarget 2016 7 42 68943 68953 27661105 5356602
Li J Cao J Li P Deng R Yao Z Ying L et al. A Bioinformatic Analysis of Immune-Related Prognostic Genes in Clear Cell Renal Cell Carcinoma Based on TCGA and GEO Databases IJGM 2022 15 325 342
Pan Q Wang L Chai S Zhang H Li B The immune infiltration in clear cell renal cell carcinoma and their clinical implications: a study based on TCGA and GEO databases J Cancer 2020 11 11 3207 3215 1:CAS:528:DC%2BB3cXhsV2ku73E 32231726 7097965
Temiz MZ Colakerol A Ulus I Kilic E Paslanmaz F Sahin S et al. Prediction of non-muscle-invasive bladder cancer recurrence during intravesical BCG immunotherapy by use of peripheral blood eosinophil count and percentage: a preliminary report Cancer Immunol Immunother 2021 70 1 245 252 1:CAS:528:DC%2BB3cXhsVKmtbnK 32700089
Nunez-Nateras R Castle EP Protheroe CA Stanton ML Ocal TI Ferrigni EN et al. Predicting response to bacillus Calmette-Guérin (BCG) in patients with carcinoma in situ of the bladder Urol Oncol 2014 32 1 45.e23 45.e30 24055426
Zaffran I Zoabi Y Gaur P Alekberli FR Tiligada E Yutkin V et al. Eosinophils but not mast cells exert anti-tumorigenic activity, without being predictive markers of the long-term response to Bacillus Calmette-Guérin (BCG) therapy in patients with bladder carcinoma Inflamm Res 2025 74 1 68 1:CAS:528:DC%2BB2MXpslynsL8%3D 40272538 12021714
Popov H, Donev IS, Ghenev P. Quantitative analysis of tumor-associated tissue eosinophilia in recurring bladder cancer. Cureus. 2018. Available from: https://www.cureus.com/articles/13143-quantitative-analysis-of-tumor-associated-tissue-eosinophilia-in-recurring-bladder-cancer. Cited 11 Nov 2024.
Ono Y Ozawa M Tamura Y Suzuki T Suzuki K Kurokawa K et al. Tumor-associated tissue eosinophilia of penile cancer Int J Urol 2002 9 2 82 87 12028296
Kalavska K Sestakova Z Mlcakova A Gronesova P Miskovska V Rejlekova K et al. Comprehensive assessment of selected immune cell subpopulations changes in chemotherapy-naïve germ cell tumor patients Front Oncol 2022 11 12 858797
Holub K Biete A New pre-treatment eosinophil-related ratios as prognostic biomarkers for survival outcomes in endometrial cancer BMC Cancer 2018 18 1 1280 1:CAS:528:DC%2BC1MXht1Ogtb%2FM 30577833 6304088
Holub K Biete A Impact of systemic inflammation biomarkers on the survival outcomes of cervical cancer patients Clin Transl Oncol 2019 21 7 836 844 1:CAS:528:DC%2BC1cXitlWnsL%2FP 30470994
Chun S Shin K Kim KH Kim HY Eo W Lee JY et al. The neutrophil-lymphocyte ratio predicts recurrence of cervical intraepithelial neoplasia J Cancer 2017 8 12 2205 2211 28819422 5560137
Bethwaite PB Holloway LJ Yeong ML Thornton A Effect of tumour associated tissue eosinophilia on survival of women with stage IB carcinoma of the uterine cervix J Clin Pathol 1993 46 11 1016 1020 1:STN:280:DyaK2c%2FnsFKqtw%3D%3D 8254087 501685
van Driel WJ Hogendoorn PCW Jansen FW Zwinderman AH Trimbos JB Fleuren GJ Tumor-associated eosinophilic infiltrate of cervical cancer is indicative for a less effective immune response Hum Pathol 1996 27 9 904 911 8816884
Onesti CE Josse C Boulet D Thiry J Beaumecker B Bours V et al. Blood eosinophilic relative count is prognostic for breast cancer and associated with the presence of tumor at diagnosis and at time of relapse OncoImmunology 2020 9 1 1761176 32923121 7458605
Ownby HE Roi LD Isenberg RR Brennan MJ Peripheral lymphocyte and eosinophil counts as indicators of prognosis in primary breast cancer Cancer 2006 52 1 126 130
Cihan YB Arslan A Cetindag MF Mutlu H Lack of prognostic value of blood parameters in patients receiving adjuvant radiotherapy for breast cancer Asian Pac J Cancer Prev 2014 15 10 4225 4231 24935375
Chouliaras K Tokumaru Y Asaoka M Oshi M Attwood KM Yoshida K et al. Prevalence and clinical relevance of tumor-associated tissue eosinophilia (TATE) in breast cancer Surgery 2021 169 5 1234 1239 32958266
Okcu O Öztürk Ç Şen B Ayazoğlu MS Güvendi GF Öztürk SD et al. The prognostic significance of non-lymphoid immune cells of the tumor microenvironment, including neutrophils, eosinophils, and mast cells in breast carcinomas Ann Diagn Pathol 2023 65 152151 37121083
Ali HR Chlon L Pharoah PDP Markowetz F Caldas C Patterns of immune infiltration in breast cancer and their clinical implications: a gene-expression-based retrospective study PLoS Med. 2016 13 12 e1002194 27959923 5154505 Ladanyi M, editor
Wang Z Zhang C Liu Y Wang Z Jiang T Peripheral blood test provides a practical method for glioma evaluation and prognosis prediction CNS Neurosci Ther 2019 25 8 876 883 1:CAS:528:DC%2BC1MXhsVSis7vN 30912613 6630006
Palapinyo S Klaewsongkram J Sriuranpong V Areepium N Incidence of oxaliplatin hypersensitivity reaction among colorectal cancer patients: A 5-year retrospective study PharmPract 2022 20 2 01 8
Okayama T Ishikawa T Sugatani K Yoshida N Kokura S Matsuda K et al. Hypersensitivity reactions to oxaliplatin: identifying the risk factors and judging the efficacy of a desensitization protocol Clin Ther 2015 37 6 1259 1269 1:CAS:528:DC%2BC2MXls1Glu7o%3D 25862137
Selcuk A, Yıldız B. Oxaliplatin-induced hypersensitivity reactions: risk factors and management. Eur Rev Med Pharmacol Sci. 2023;27(6):2640–5.
Hu G Wang S Zhong K Xu F Huang L Chen W et al. Tumor-associated tissue eosinophilia predicts favorable clinical outcome in solid tumors: a meta-analysis BMC Cancer 2020 20 1 454 1:CAS:528:DC%2BB3cXpvFClsrg%3D 32434481 7240929
Lagisetty KH McEwen DP Nancarrow DJ Schiebel JG Ferrer-Torres D Ray D et al. Immune determinants of Barrett’s progression to esophageal adenocarcinoma JCI Insight 2021 6 1 e143888 33290281 7821593
Jacobse J, Aziz Z, Sun L, Chaparro J, Pilat JM, Kwag A, et al. Eosinophils exert direct and indirect anti-tumorigenic effects in the development of esophageal squamous cell carcinoma. bioRxiv [Preprint]. Cell Mol Gastroenterol Hepatol. 2023;16(6):961–983. https://doi.org/10.1101/2023.06.01.543287.
Uchida AM Schuman SS Pyne A Peterson K Carlson M Garber JJ et al. Risk of cancer diagnosis in patients with eosinophilic esophagitis using a nationwide Swedish population cohort UEG J 2024 12 10 1378 1387 1:CAS:528:DC%2BB2cXisF2ntb%2FI
Syed A Maradey-Romero C Fass R The relationship between eosinophilic esophagitis and esophageal cancer Dis Esophagus 2017 30 7 1 5 1:STN:280:DC%2BB3c7is1Chsw%3D%3D 30052901
Albaneze N Cotton CC Anderson C Katzka DA Dellon ES No Association between eosinophilic oesophagitis and oesophageal cancer in US adults: a case-control study Aliment Pharmacol Ther 2025 61 2 363 368 39629856
Fuller AD Karami AL Kabir MF Klochkova A Jackson JL Mu A et al. Eosinophilic esophagitis-associated epithelial remodeling may limit esophageal carcinogenesis Front Allergy 2023 29 4 1086032
Privitera G Williams JJ De Salvo C The Importance of Th2 Immune Responses in Mediating the Progression of Gastritis-Associated Metaplasia to Gastric Cancer Cancers 2024 16 3 522 1:CAS:528:DC%2BB2cXjvVemtbY%3D 38339273 10854712
Abu-Shawer O Abu-Shawer M Shurman A Lattouf A Haimour A Hamdan O et al. The clinical value of peripheral immune cell counts in pancreatic cancer PLoS One. 2020 15 6 e0232043 1:CAS:528:DC%2BB3cXht1Sjt7vF 32542007 7295193 Scarpa A, editor
Oliveira DT Biassi TP Faustino SES Carvalho AL Landman G Kowalski LP Eosinophils may predict occult lymph node metastasis in early oral cancer Clin Oral Invest 2012 16 6 1523 1528 1:STN:280:DC%2BC38zovVSmsg%3D%3D
Chen Q Shen L Li S Tumor volume reduction after induction chemotherapy with gemcitabine plus cisplatin in nasopharyngeal carcinoma Eur Arch Otorhinolaryngol 2023 280 5 2497 2509 36572820
Zhong R Chen D Cao S Li J Han B Zhong H Immune cell infiltration features and related marker genes in lung cancer based on single-cell RNA-seq Clin Transl Oncol 2021 23 2 405 417 1:CAS:528:DC%2BB3cXhsVSrs7rE 32656582
Hamdan D Leboeuf C Le Foll C Bousquet G Janin A Re‐exploring immune‐related side effects of docetaxel in an observational study: blood hypereosinophilia Cancer Med 2019 8 5 2005 2012 1:CAS:528:DC%2BC1MXhtVygtr%2FI 30854809 6537007
Ferro M Musi G Serino A Cozzi G Mistretta FA Costa B et al. Neutrophil, platelets, and eosinophil to lymphocyte ratios predict gleason score upgrading in low-risk prostate cancer patients Urol Int 2019 102 1 43 50 1:CAS:528:DC%2BC1MXht1yrtbk%3D 30408799
Haberal HB Artykov M Hazir B Citamak B Altan M Yazici S et al. Predictors of ISUP score upgrade in patients with low-risk prostate cancer Tumori 2021 107 3 254 260 1:CAS:528:DC%2BB3MXhtV2gtLfJ 32727308
Cihan YB Arslan A Ergul MA Subtypes of white blood cells in patients with prostate cancer or benign prostatic hyperplasia and healthy individuals Asian Pac J Cancer Prev 2013 14 8 4779 4783 24083743
Hayashi T Fujita K Tanigawa G Kawashima A Nagahara A Ujike T et al. Serum monocyte fraction of white blood cells is increased in patients with high Gleason score prostate cancer Oncotarget 2017 8 21 35255 35261 27823973 5471051
Weide B Martens A Hassel JC Berking C Postow MA Bisschop K et al. Baseline Biomarkers for outcome of melanoma patients treated with Pembrolizumab Clin Cancer Res 2016 22 22 5487 5496 1:CAS:528:DC%2BC28XhvVCqur3K 27185375 5572569
Martens A Wistuba-Hamprecht K Foppen MG Yuan J Postow MA Wong P et al. Baseline peripheral blood biomarkers associated with clinical outcome of advanced melanoma patients treated with ipilimumab Clin Cancer Res 2016 22 12 2908 2918 1:CAS:528:DC%2BC28XhtVSltLjN 26787752 5770142
Ammann NL Schwietzer YF Mess C Stadler JC Geidel G Kött J et al. Activated eosinophils predict longer progression-free survival under immune checkpoint inhibition in melanoma Cancers 2022 14 22 5676 1:CAS:528:DC%2BB38XjtVSjtrbN 36428768 9688620
Ferrucci PF Gandini S Cocorocchio E Pala L Baldini F Mosconi M et al. Baseline relative eosinophil count as a predictive biomarker for ipilimumab treatment in advanced melanoma Oncotarget 2017 8 45 79809 79815 29108362 5668095
Takeuchi E Kondo K Okano Y Ichihara S Kunishige M Kadota N et al. Pretreatment eosinophil counts as a predictive biomarker in non‐small cell lung cancer patients treated with immune checkpoint inhibitors Thorac Cancer 2023 14 30 3042 3050 1:CAS:528:DC%2BB3sXhvVGks7bN 37669914 10599974
Caliman E Fancelli S Ottanelli C Mazzoni F Paglialunga L Lavacchi D et al. Absolute eosinophil count predicts clinical outcomes and toxicity in non-small cell lung cancer patients treated with immunotherapy Cancer Treat Res Commun 2022 32 100603 35792426
Okauchi S, Shiozawa T, Miyazaki K, Nishino K, Sasatani Y, Ohara G, et al. Association between peripheral eosinophils and clinical outcome in non-small cell lung cancer patients treated with immune checkpoint inhibitors. Polish Arch Internal Med. 2021. Available from: https://www.mp.pl/paim/issue/article/15776. Cited 28 Aug 2023.
Beulque Y Kinget L Roussel E Mobaraki S Laenen A Debruyne PR et al. Baseline neutrophil-to-eosinophil-ratio and outcome in metastatic clear-cell renal cell carcinoma treated with nivolumab or ipilimumab/nivolumab AO 2024 11 63 658 668
Zahoor H Barata PC Jia X Martin A Allman KD Wood LS et al. Patterns, predictors and subsequent outcomes of disease progression in metastatic renal cell carcinoma patients treated with nivolumab j immunotherapy cancer 2018 6 1 107
Chen X Liu H Pan D Yao Z Han Z Qu P Predictive value of peripheral blood eosinophil count on the efficacy of treatment with camrelizumab in combination with lenvatinib in patients with advanced hepatitis B-associated hepatocellular carcinoma Technol Cancer Res Treat 2024 23 15330338241277695 1:CAS:528:DC%2BB2MXjsVGitA%3D%3D 39263703 11406659
Rossari F Tada T Suda G Shimose S Kudo M Yoo C et al. Disease etiology impact on outcomes of hepatocellular carcinoma patients treated with atezolizumab plus bevacizumab: a real-world Multicenter Study Liver Cancer 2024 13 5 522 536 1:CAS:528:DC%2BB2cXitlSisbnM 39296620 11407762
Toshida K Itoh S Yoshiya S Nagao Y Tomino T Izumi T et al. Pretreatment eosinophil count predicts response to atezolizumab plus bevacizumab therapy in patients with hepatocellular carcinoma J Gastro Hepatol 2024 39 3 576 586 1:CAS:528:DC%2BB3sXis1CgsLbO
Mota JM Teo MY Whiting K Li HA Regazzi AM Lee CH et al. Pretreatment eosinophil counts in patients with advanced or metastatic urothelial carcinoma treated with anti-PD-1/PD-L1 checkpoint inhibitors J Immunother 2021 44 7 248 253 1:CAS:528:DC%2BB3MXhsl2qtbrK 34081050 8373810
Nishikawa D Suzuki H Beppu S Terada H Sawabe M Kadowaki S et al. Eosinophil prognostic scores for patients with head and neck squamous cell carcinoma treated with nivolumab Cancer Sci 2021 112 1 339 346 1:CAS:528:DC%2BB3cXit1ChsbfO 33078505
Minohara K Matoba T Kawakita D Takano G Oguri K Murashima A et al. Novel Prognostic Score for recurrent or metastatic head and neck cancer patients treated with Nivolumab Sci Rep 2021 11 1 16992 1:CAS:528:DC%2BB3MXhvVGns7vF 34417539 8379150
Delyon J Mateus C Lefeuvre D Lanoy E Zitvogel L Chaput N et al. Experience in daily practice with ipilimumab for the treatment of patients with metastatic melanoma: an early increase in lymphocyte and eosinophil counts is associated with improved survival Ann Oncol 2013 24 6 1697 1703 1:STN:280:DC%2BC3svhtFOhsA%3D%3D 23439861
Bernard-Tessier A Jeanville P Champiat S Lazarovici J Voisin AL Mateus C et al. Immune-related eosinophilia induced by anti-programmed death 1 or death-ligand 1 antibodies Eur J Cancer 2017 81 135 137 1:CAS:528:DC%2BC2sXpvVKitLs%3D 28624693
Simon SCS Hu X Panten J Grees M Renders S Thomas D et al. Eosinophil accumulation predicts response to melanoma treatment with immune checkpoint inhibitors Oncoimmunology 2020 9 1 1727116 32117594 7028332
Gebhardt C Sevko A Jiang H Lichtenberger R Reith M Tarnanidis K et al. Myeloid cells and related chronic inflammatory factors as novel predictive markers in melanoma treatment with ipilimumab Clin Cancer Res 2015 21 24 5453 5459 1:CAS:528:DC%2BC2MXitVKjs7vL 26289067
Huai Q Luo C Song P Bie F Bai G Li Y et al. Peripheral blood inflammatory biomarkers dynamics reflect treatment response and predict prognosis in non‐small cell lung cancer patients with neoadjuvant immunotherapy Cancer Sci 2023 114 12 4484 4498 1:CAS:528:DC%2BB3sXhvF2ntr%2FE 37731264 10728017
Hwang M Canzoniero JV Rosner S Zhang G White JR Belcaid Z et al. Peripheral blood immune cell dynamics reflect antitumor immune responses and predict clinical response to immunotherapy J Immunother Cancer 2022 10 6 e004688 35688557 9189831
Sibille A Henket M Corhay JL Alfieri R Louis R Duysinx B White blood cells in patients treated with programmed cell death-1 inhibitors for non-small cell lung cancer Lung 2021 199 5 549 557 1:CAS:528:DC%2BB3MXis12hsrjJ 34518898 8510914
Osawa H, Shiozawa T, Okauchi S, Miyazaki K, Kodama T, Kagohashi K, et al. Time-to-treatment failure and peripheral eosinophils in non-small cell lung cancer patients treated with immune checkpoint inhibitors. Polish Arch Internal Med. 2021. Available from: https://www.mp.pl/paim/issue/article/16049. Cited 11 Nov 2024.
Yoshimura A Nagahara A Ishizuya Y Yamamoto Y Hatano K Kawashima A et al. The prognostic impact of peripheral blood eosinophil counts in metastatic renal cell carcinoma patients treated with nivolumab Clin Exp Med 2024 24 1 111 1:CAS:528:DC%2BB2cXht1eisrbM 38780659 11116198
Lang BM Peveling-Oberhag A Faidt D Hötker AM Weyer-Elberich V Grabbe S et al. Long-term survival with modern therapeutic agents against metastatic melanoma—vemurafenib and ipilimumab in a daily life setting Med Oncol 2018 35 3 24 1:STN:280:DC%2BC1MvmtV2mug%3D%3D 29387968
Takeuchi E Ogino H Kondo K Okano Y Ichihara S Kunishige M et al. An increased relative eosinophil count as a predictive dynamic biomarker in non‐small cell lung cancer patients treated with immune checkpoint inhibitors Thorac Cancer 2024 15 3 248 257 1:CAS:528:DC%2BB3sXis1CgsLfK 38087769
Furubayashi N Minato A Negishi T Sakamoto N Song Y Hori Y et al. Association between immune-related adverse events and efficacy and changes in the relative eosinophil count among patients with advanced urothelial carcinoma treated by pembrolizumab CMAR 2022 Volume 14 1641 1651
Herrmann T Ginzac A Molnar I Bailly S Durando X Mahammedi H Eosinophil counts as a relevant prognostic marker for response to nivolumab in the management of renal cell carcinoma: a retrospective study Cancer Med 2021 10 19 6705 6713 1:CAS:528:DC%2BB3MXitVylsbzM 34405573 8495279
Moreira A Leisgang W Schuler G Heinzerling L Eosinophilic count as a biomarker for prognosis of melanoma patients and its importance in the response to immunotherapy Immunotherapy 2017 9 2 115 121 1:CAS:528:DC%2BC2sXhslWgt7Y%3D 28128709
Alves A Dias M Campainha S Barroso A Peripheral blood eosinophilia may be a prognostic biomarker in non-small cell lung cancer patients treated with immunotherapy J Thorac Dis 2021 13 5 2716 2727 34164164 8182546
Ghebeh H, Elshenawy MA, AlSayed AD, Al-Tweigeri T. Peripheral blood eosinophil count is associated with response to chemoimmunotherapy in metastatic triple-negative breast cancer. Immunotherapy. 2022;14(4):189–99.
Verhaart SL Abu-Ghanem Y Mulder SF Oosting S Van Der Veldt A Osanto S et al. Real-world data of nivolumab for patients with advanced renal cell carcinoma in the Netherlands: an analysis of toxicity, efficacy, and predictive markers Clin Genitourin Cancer 2021 19 3 274.e1 274.e16 33317946
Singh N Lubana SS Constantinou G Leaf AN Immunocheckpoint Inhibitor- (Nivolumab-) associated hypereosinophilia in non-small-cell lung carcinoma Case Rep Oncol Med 2020 15 2020 1 5
Mehra T Dongre K Boesing M Frei P Suenderhauf C Zippelius A et al. Pre-treatment comorbidities, C-reactive protein and eosinophil count, and immune-related adverse events as predictors of survival with checkpoint inhibition for multiple tumour entities Cancer Med 2023 12 11 12253 12262 1:CAS:528:DC%2BB3sXosVSnsbg%3D 37084178 10278511
Sahin TK Ayasun R Rizzo A Guven DC Prognostic value of Neutrophil-to-Eosinophil Ratio (NER) in cancer: a systematic review and meta-analysis Cancers 2024 16 21 3689 1:CAS:528:DC%2BB2cXisFWksrzO 39518127 11545344
Gambale E Maruzzo M Messina C De Gennaro Aquino I Vascotto IA Rossi V et al. Neutrophil-to-eosinophil ratio predicts the efficacy of avelumab in patients with advanced urothelial carcinoma enrolled in the MALVA study (Meet-URO 25) Clin Genitourin Cancer 2024 22 4 102099 38776583
Chen YW Tucker MD Brown LC Yasin HA Ancell KK Armstrong AJ et al. The Association between a Decrease in On-Treatment Neutrophil-to-Eosinophil Ratio (NER) at Week 6 after Ipilimumab Plus Nivolumab Initiation and Improved Clinical Outcomes in Metastatic Renal Cell Carcinoma Cancers 2022 14 15 3830 1:CAS:528:DC%2BB38XitFGgt7vF 35954493 9367298
Zhou J Du Z Fu J Yi X Blood cell counts can predict adverse events of immune checkpoint inhibitors: a systematic review and meta-analysis Front Immunol 2023 14 7 1117447 1:CAS:528:DC%2BB3sXnsVehsb0%3D 36960068 10029759
Tasaki Y Sugiyama Y Hamamoto S Naiki T Uemura T Yokota K et al. Eosinophil may be a predictor of immune‐related adverse events induced by different immune checkpoint inhibitor types: a retrospective multidisciplinary study Cancer Med 2023 12 24 21666 21679 1:CAS:528:DC%2BB3sXisVSktL3E 37986680 10757154
Du Y Zhang Y Zhao W Zhang Y Su F Zhang X et al. Predictive value of near-term prediction models for severe immune-related adverse events in malignant tumor PD-1 inhibitor therapy Hum Vaccin Immunother 2024 20 1 2398309 39267589 11404634
Bai R Chen N Chen X Li L Song W Li W et al. Analysis of characteristics and predictive factors of immune checkpoint inhibitor-related adverse events Cancer Biol Med 2021 18 4 1118 1133 1:CAS:528:DC%2BB38XlvFWnu7w%3D 34259422 8610160
Ma Y Ma X Wang J Wu S Wang J Cao B Absolute eosinophil count may be an optimal peripheral blood marker to identify the risk of immune-related adverse events in advanced malignant tumors treated with PD-1/PD-L1 inhibitors: a retrospective analysis World J Surg Oncol 2022 20 1 242 35897018 9331074
Ueki Y Ohshima S Omata J Yokoyama Y Takahashi T Shodo R et al. Role of eosinophilia in patients with recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab: prediction of immune‐related adverse events and favorable outcome Cancer Med 2023 12 22 20810 20820 1:CAS:528:DC%2BB3sXit12nt7jE 37902133 10709726
Yoshikawa Y Imamura M Yamauchi M Hayes CN Aikata H Okamoto W et al. Prevalence of immune-related adverse events and anti-tumor efficacy following immune checkpoint inhibitor therapy in Japanese patients with various solid tumors BMC Cancer 2022 22 1 1232 36447159 9706984
Hadfield MJ Merkin RD Rouhani SJ Reynolds KL Precision immunomodulation: understanding and harnessing cytokine pathways to treat and prevent immune-related adverse events (irAEs) Best Pract Res Clin Haematol 2025 38 2 101625 1:CAS:528:DC%2BB2MXisVCgtL3E 40701736
Zalewska E Obołończyk Ł Sworczak K Hypereosinophilia in solid tumors—case report and clinical review Front Oncol 2021 24 11 639395
Videla EK De La Torre B Ferrada P Miller J Torres E Álvarez A et al. Hipereosinofilia severa como síndrome paraneoplásico en un paciente con cáncer diferenciado de tiroides Rev Fac Cien Med Univ Nac Cordoba 2024 81 2 403 414 38941219 11370870
Zhou WW Guan YY Liu XM Paraneoplastic eosinophilia in clear cell renal cell carcinoma Chin Med J 2015 128 16 2271 2272 26265628 4717976
Abughanimeh O, Tahboub M, Abu Ghanimeh M. Metastatic Lung Adenocarcinoma Presenting with Hypereosinophilia. Cureus. 2018. Available from: https://www.cureus.com/articles/12874-metastatic-lung-adenocarcinoma-presenting-with-hypereosinophilia. Cited 11 Nov 2024.
Cohen EM Russeth TE Thati N Hypereosinophilia as a presenting sign of advanced pancreatic adenocarcinoma: a rare, severe presentation BMJ Case Rep 2023 16 12 e256235 38151269 10753747
Tsunematsu M Haruki K Uwagawa T Shiba H Yanaga K Gallbladder cancer accompanied by uncontrollable eosinophilia: report of a case Int Canc Conf J 2020 9 2 55 58
Hasan Albitar HA Egan AM Alkhateeb H Almodallal Y Iyer VN Marked hypereosinophilia secondary to endometrioid ovarian cancer presenting with asthma symptoms, a case report Respir Med Case Rep 2020 31 101178 32775193 7404536
Harsha BS Manikandan R Sreerag KS Dorairajan LN Rajesh NG Kar R Eosinophilic leukemoid reaction with eosinophilic tumor tissue infiltration as an extermely poor prognostic factor in urinary bladder cancer- a known entity revisited Pathol Oncol Res 2020 26 4 2817 2819 32227297
Goto Y Tamura D Matsuura T Shiomi E Ikarashi D Maekawa S et al. Successful treatment of eosinophilia associated with dialysis-related renal cancer with radical nephrectomy IJU Case Reports 2024 7 4 301 304 38966767 11221936
Ellez Hİ, Bayram E, Demirciler E, Semiz HS. Paraneoplastic Hypereosinophilia in Locally Advanced Clear Cell Renal Carcinoma. Cureus. 2023. Available from: https://www.cureus.com/articles/160248-paraneoplastic-hypereosinophilia-in-locally-advanced-clear-cell-renal-carcinoma. Cited 11 Nov 2024.
Inoue M Kadono J Sugita H Nakazono T Motoi S Kitazono I et al. Impact of chemotherapy on eosinophilia-associated advanced rectal cancer: A case report and review of the literature Oncol Lett 2016 12 6 5269 5274 28105235 5228383
Ferrão D, Silva C, Almeida JS. Pulmonary adenocarcinoma presenting as acute heart failure and hypereosinophilia. Cureus. 2022. Available from: https://www.cureus.com/articles/83197-pulmonary-adenocarcinoma-presenting-as-acute-heart-failure-and-hypereosinophilia. Cited 11 Nov 2024.
Rajpara A, Liolios A, Fraga G, Blackmon J. Recurrent paraneoplastic wells syndrome in a patient with metastatic renal cell cancer. Dermatol Online J. 2014;20(6). Available from: https://escholarship.org/uc/item/35w8r1g3. Cited 7 Aug 2025.
Burnet FM. The concept of immunological surveillance. In: Schwartz RS, editor. Progress in Tumor Research. S. Karger AG; 1970. pp. 1–27. Available from: https://karger.com/chapter/doi/10.1159/000386035. Cited 21 Aug 2025.
Chu VT Beller A Rausch S Strandmark J Zänker M Arbach O et al. Eosinophils promote generation and maintenance of immunoglobulin-A-expressing plasma cells and contribute to gut immune homeostasis Immunity 2014 40 4 582 593 1:CAS:528:DC%2BC2cXmsVKksL8%3D 24745334
Reichman H Itan M Rozenberg P Yarmolovski T Brazowski E Varol C et al. Activated eosinophils exert antitumorigenic activities in colorectal cancer Cancer Immunol Res 2019 7 3 388 400 1:CAS:528:DC%2BB3cXhtl2ksbnJ 30665890
Simson L Ellyard JI Dent LA Matthaei KI Rothenberg ME Foster PS et al. Regulation of carcinogenesis by IL-5 and CCL11: a potential role for eosinophils in tumor immune surveillance J Immunol 2007 178 7 4222 4229 1:CAS:528:DC%2BD2sXjt1Wlur4%3D 17371978
De Salvo C Pastorelli L Petersen CP Buttò LF Buela KA Omenetti S et al. Interleukin 33 triggers early eosinophil-dependent events leading to metaplasia in a chronic model of gastritis-prone mice Gastroenterology 2021 160 1 302 316.e7 1:CAS:528:DC%2BB3MXhs1Ojt7k%3D 33010253
Wong DTW Bowen SM Elovic A Gallagher GT Weller PF Eosinophil ablation and tumor development Oral Oncol 1999 35 5 496 501 1:CAS:528:DyaK1MXlsFCht7g%3D 10694950
Xie F Liu LB Shang WQ Chang KK Meng YH Mei J et al. The infiltration and functional regulation of eosinophils induced by TSLP promote the proliferation of cervical cancer cell Cancer Lett 2015 364 2 106 117 1:CAS:528:DC%2BC2MXos1emtrw%3D 25979231
da Silva JM, Queiroz-Junior CM, Batista AC, Rachid MA, Teixeira MM, da Silva TA. Eosinophil depletion protects mice from tongue squamous cell carcinoma induced by 4-nitroquinoline-1-oxide. Histol Histopathol. 2014;29(3):387–96.
Cederberg RA Franks SE Wadsworth BJ So A Decotret LR Hall MG et al. Eosinophils decrease pulmonary metastatic mammary tumor growth Front Oncol 2022 8 12 841921
Ikutani M Yanagibashi T Ogasawara M Tsuneyama K Yamamoto S Hattori Y et al. Identification of Innate IL-5–producing cells and their role in lung eosinophil regulation and antitumor immunity J Immunol 2012 188 2 703 713 1:CAS:528:DC%2BC38XjvVCitg%3D%3D 22174445
Lucarini V Ziccheddu G Macchia I La Sorsa V Peschiaroli F Buccione C et al. IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophils OncoImmunology 2017 6 6 e1317420 28680750 5486175
Kienzl M Hasenoehrl C Valadez-Cosmes P Maitz K Sarsembayeva A Sturm E et al. IL-33 reduces tumor growth in models of colorectal cancer with the help of eosinophils OncoImmunology 2020 9 1 1776059 32923137 7458617
Perales-Puchalt A Svoronos N Villarreal DO Zankharia U Reuschel E Wojtak K et al. IL-33 delays metastatic peritoneal cancer progression inducing an allergic microenvironment OncoImmunology 2019 8 1 e1515058 30546956
Grisaru-Tal S Itan M Klion AD Munitz A A new dawn for eosinophils in the tumour microenvironment Nat Rev Cancer 2020 20 10 594 607 1:CAS:528:DC%2BB3cXhsVSrt7nM 32678342
Caruso RA Parisi A Quattrocchi E Scardigno M Branca G Parisi C et al. Ultrastructural descriptions of heterotypic aggregation between eosinophils and tumor cells in human gastric carcinomas Ultrastruct Pathol 2011 35 4 145 149 21657821
Gatault S Delbeke M Driss V Sarazin A Dendooven A Kahn JE et al. IL-18 Is Involved in Eosinophil-Mediated Tumoricidal Activity against a Colon Carcinoma Cell Line by Upregulating LFA-1 and ICAM-1 J Immunol 2015 195 5 2483 2492 1:CAS:528:DC%2BC2MXhtlOjurvK 26216891
Clarke CA Smith MA Laniyan I Vaughn TR Parish-Gause D Green W et al. Eosinophil MBP extract modulates oncogene expression in prostate tumor cells: a preliminary study with monolayer cultures J Cancer Ther 2015 06 06 482 492
Kataoka S Konishi Y Nishio Y Fujikawa-Adachi K Tominaga A Antitumor activity of eosinophils activated by IL-5 and eotaxin against hepatocellular carcinoma DNA Cell Biol 2004 23 9 549 560 1:CAS:528:DC%2BD2cXns1ersrg%3D 15383175
Vieira BM De São José VS Niemeyer Filho PS Moura-Neto V Eosinophils induces glioblastoma cell suppression and apoptosis – roles of GM-CSF and cysteinyl-leukotrienes Int Immunopharmacol 2023 123 110729 1:CAS:528:DC%2BB3sXhs1amsLnM 37536182
Caruso R, Caruso V, Rigoli L. Ultrastructural evidence of eosinophil clustering and ETosis in association with damage to single tumour cells in a case of poorly cohesive NOS gastric carcinoma. Eur J Case Rep Internal Med. 2023. Available from: https://www.ejcrim.com/index.php/EJCRIM/article/view/4016. Cited 11 Nov 2024.
Carretero R Sektioglu IM Garbi N Salgado OC Beckhove P Hämmerling GJ Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8+ T cells Nat Immunol 2015 16 6 609 617 1:CAS:528:DC%2BC2MXntFCitbs%3D 25915731
Gambardella AR Antonucci C Zanetti C Noto F Andreone S Vacca D et al. IL-33 stimulates the anticancer activities of eosinophils through extracellular vesicle-driven reprogramming of tumor cells J Exp Clin Cancer Res 2024 43 1 209 1:CAS:528:DC%2BB2cXhs1Cju7bM 39061080 11282757
Arnold IC Artola-Boran M Gurtner A Bertram K Bauer M Frangez Z et al. The GM-CSF–IRF5 signaling axis in eosinophils promotes antitumor immunity through activation of type 1 T cell responses J Exp Med 2020 217 12 e20190706 1:CAS:528:DC%2BB3cXit1GmtbvE 32970801 7953737
Grisaru-Tal S Dulberg S Beck L Zhang C Itan M Hediyeh-zadeh S et al. Metastasis-entrained eosinophils enhance lymphocyte-mediated antitumor immunity Can Res 2021 81 21 5555 5571 1:CAS:528:DC%2BB3MXisl2rurfF
Qi L Zhang Q Miao Y Kang W Tian Z Xu D et al. Interleukin‐33 activates and recruits natural killer cells to inhibit pulmonary metastatic cancer development Int J Cancer 2020 146 5 1421 1434 1:CAS:528:DC%2BC1MXit12rsb%2FP 31709531
Lotfi R Lotze MT Eosinophils induce DC maturation, regulating immunity J Leukoc Biol 2008 83 3 456 460 1:CAS:528:DC%2BD1cXjtVaqsbc%3D 17991762
Handler K, Raju D, Gurtner A, Dalessi T, Brügger MD, Crepaz D, et al. Eosinophils restrict CRC metastasis by inhibiting pro-tumorigenic SPP1+ macrophage differentiation. 2024. Available from: http://biorxiv.org/lookup/doi/10.1101/2024.12.13.628333. Cited 11 Aug 2024.
Garro AP Chiapello LS Baronetti JL Masih DT Rat eosinophils stimulate the expansion of Cryptococcus neoformans-specific CD4+ and CD8+ T cells with a T-helper 1 profile: eosinophil as C. neoformans antigen-presenting cell Immunology 2011 132 2 174 187 1:CAS:528:DC%2BC3MXhsl2mt7g%3D 21039463
Shani O Vorobyov T Monteran L Lavie D Cohen N Raz Y et al. Fibroblast-Derived IL33 Facilitates Breast Cancer Metastasis by Modifying the Immune Microenvironment and Driving Type 2 Immunity Can Res 2020 80 23 5317 5329 1:CAS:528:DC%2BB3MXjsFGgsA%3D%3D
Li F Du X Lan F Li N Zhang C Zhu C et al. Eosinophilic inflammation promotes CCL6-dependent metastatic tumor growth Sci Adv. 2021 7 22 eabb5943 1:CAS:528:DC%2BB3MXhvVersrzJ 34039594 8153717
LaMarche NM Hegde S Park MD Maier BB Troncoso L Le Berichel J et al. An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis Nature 2024 625 7993 166 174 1:CAS:528:DC%2BB3sXisFGhu7jL 38057662
Zaynagetdinov R Sherrill TP Gleaves LA McLoed AG Saxon JA Habermann AC et al. Interleukin-5 Facilitates Lung Metastasis by Modulating the Immune Microenvironment Can Res 2015 75 8 1624 1634 1:CAS:528:DC%2BC2MXmsV2lsLo%3D
Zhang Y Yang P Cui R Zhang M Li H Qian C et al. Eosinophils reduce chronic inflammation in adipose tissue by secreting Th2 cytokines and promoting M2 macrophages polarization Int J Endocrinol 2015 2015 1 5
Walsh MT Connell K Sheahan AM Gleich GJ Costello RW Eosinophil peroxidase signals via epidermal growth factor–2 to induce cell proliferation Am J Respir Cell Mol Biol 2011 45 5 946 952 1:CAS:528:DC%2BC3MXhsV2nsbjJ 21454806
Panagopoulos V Leach DA Zinonos I Ponomarev V Licari G Liapis V et al. Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironment Int J Oncol 2017 50 4 1191 1200 1:CAS:528:DC%2BC1cXjs1yis7g%3D 28260049
Willems M Hamaidia M Fontaine A Grégoire M Halkin L Vilanova Mañá L et al. The impact of Charcot-Leyden Crystal protein on mesothelioma chemotherapy: targeting eosinophils for enhanced chemosensitivity EBioMedicine 2024 109 105418 1:CAS:528:DC%2BB2cXisVWnt7vN 39471751 11550731
Furbert‐Harris P Parish‐Gause D Laniyan I Hunter KA Okomo‐Awich J Vaughn TR et al. Inhibition of prostate cancer cell growth by activated eosinophils Prostate 2003 57 2 165 175 12949941
Andreone S Spadaro F Buccione C Mancini J Tinari A Sestili P et al. IL-33 Promotes CD11b/CD18-mediated adhesion of eosinophils to cancer cells and synapse-polarized degranulation leading to tumor cell killing Cancers 2019 11 11 1664 1:CAS:528:DC%2BB3cXns1GksLY%3D 31717819 6895824
Huang WY Lin YS Lin YC Nieh S Chang YM Lee TY et al. Cancer-Associated Fibroblasts Promote Tumor Aggressiveness in Head and Neck Cancer through Chemokine Ligand 11 and C-C Motif Chemokine Receptor 3 Signaling Circuit Cancers 2022 14 13 3141 1:CAS:528:DC%2BB38XhvVehurnE 35804913 9264987
Cheng OJ Lebish EJ Jensen O Jacenik D Trivedi S Cacioppo JG et al. Mucosal-associated invariant T cells modulate innate immune cells and inhibit colon cancer growth Scand J Immunol 2024 100 3 e13391 1:CAS:528:DC%2BB2cXht1CqsbnL 38773691 11315626
Mattei F, Andreone S, Marone G, Gambardella AR, Loffredo S, Varricchi G, et al. Eosinophils in the tumor microenvironment. In: Birbrair A, editor. Tumor Microenvironment: Hematopoietic Cells – Part B. Cham; 2020. Available from: http://link.springer.com/10.1007/978-3-030-49270-0. Cited 22 Sep 2023.
Hollande C Boussier J Ziai J Nozawa T Bondet V Phung W et al. Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth Nat Immunol 2019 20 3 257 264 1:CAS:528:DC%2BC1MXnsVCitbo%3D 30778250
Bhattacharyya S Oon C Diaz L Sandborg H Stempinski ES Saoi M et al. Autotaxin–lysolipid signaling suppresses a CCL11–eosinophil axis to promote pancreatic cancer progression Nat Cancer 2024 5 2 283 298 1:CAS:528:DC%2BB2cXht1Sqs7g%3D 38195933 10899115
Cormier SA Taranova AG Bedient C Nguyen T Protheroe C Pero R et al. Pivotal Advance: Eosinophil infiltration of solid tumors is an early and persistent inflammatory host response J Leukoc Biol 2006 79 6 1131 1139 1:CAS:528:DC%2BD28XlvVerur8%3D 16617160 3496422
Artham S Juras PK Goyal A Chakraborty P Byemerwa J Liu S et al. Estrogen signaling suppresses tumor-associated tissue eosinophilia to promote breast tumor growth Sci Adv. 2024 10 39 eadp2442 1:CAS:528:DC%2BB2cXisVentr%2FP 39331714 11430468
Ghaffari S Rezaei N Eosinophils in the tumor microenvironment: implications for cancer immunotherapy J Transl Med 2023 21 1 551 1:CAS:528:DC%2BB3sXhslansrzI 37587450 10433623
Blomberg OS Spagnuolo L Garner H Voorwerk L Isaeva OI Van Dyk E et al. IL-5-producing CD4+ T cells and eosinophils cooperate to enhance response to immune checkpoint blockade in breast cancer Cancer Cell 2023 41 1 106 123.e10 1:CAS:528:DC%2BB38XjtFWqu7%2FN 36525971
Zheng X Zhang N Qian L Wang X Fan P Kuai J et al. CTLA4 blockade promotes vessel normalization in breast tumors via the accumulation of eosinophils Intl Journal of Cancer 2020 146 6 1730 1740 1:CAS:528:DC%2BC1MXisVyqtbbI
Jacobsen EA Jackson DJ Heffler E Mathur SK Bredenoord AJ Pavord ID et al. Eosinophil Knockout Humans: Uncovering the Role of Eosinophils Through Eosinophil-Directed Biological Therapies Annu Rev Immunol 2021 39 1 719 757 1:CAS:528:DC%2BB3MXltl2hsb8%3D 33646859 8317994
Ackerman SJ Stacy NI Considerations on the evolutionary biology and functions of eosinophils: what the “haeckel”? J Leukoc Biol 2024 116 2 247 259 1:CAS:528:DC%2BB2MXhvFWgsLfF 38736141 11288384
Dolitzky A Hazut I Avlas S Grisaru-Tal S Itan M Zaffran I et al. Differential regulation of type 1 and type 2 mouse eosinophil activation by apoptotic cells Front Immunol 2022 13 31 1041660 1:CAS:528:DC%2BB38XivFOisL%2FF 36389786 9662748
Ecrement A Spasovski V Rolin G Barnig C Exploring the diversity and emerging powers of eosinophil subpopulations Allergy 2025 80 11 3012 3026 1:CAS:528:DC%2BB2MXhvF2ms7jP 40568764
Jackson DJ Pavord ID Living without eosinophils: evidence from mouse and man Eur Respir J 2023 61 1 2201217 1:CAS:528:DC%2BB3sXnt12htrg%3D 35953100 9834633
